Daiichi Sankyo sales and marketing update

The U.K.’s NICE issued a final appraisal determination (FAD) for Lixiana edoxaban from Daiichi to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) in adults. In June, the Euro...